1 |
28030
|
alessia.ba
|
<oaf:entity xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
|
2 |
|
|
xmlns:oaf="http://namespace.openaire.eu/oaf"
|
3 |
|
|
xsi:schemaLocation="http://namespace.openaire.eu/oaf ../schema/oaf-0.1.xsd">
|
4 |
|
|
<oaf:person>
|
5 |
|
|
<firstname>C</firstname>
|
6 |
|
|
<secondnames>Overmeir</secondnames>
|
7 |
|
|
<fullname>Overmeir, C.</fullname>
|
8 |
|
|
<fax/>
|
9 |
|
|
<email/>
|
10 |
|
|
<phone/>
|
11 |
|
|
<nationality classid="" classname="" schemeid="" schemename=""/>
|
12 |
|
|
<originalId/>
|
13 |
|
|
<originalId/>
|
14 |
|
|
<originalId/>
|
15 |
|
|
<originalId/>
|
16 |
|
|
<originalId/>
|
17 |
|
|
<originalId/>
|
18 |
|
|
<collectedfrom name="Search4Dev" id="opendoar____::856fc81623da2150ba2210ba1b51d241"/>
|
19 |
|
|
<collectedfrom
|
20 |
|
|
name="D&#233;p&#244;t Institutionnel de l&apos;Acad&#233;mie universitaire &apos;Louvain&apos;"
|
21 |
|
|
id="opendoar____::1714726c817af50457d810aae9d27a2e"/>
|
22 |
|
|
<collectedfrom name="Tropmed Central Antwerp"
|
23 |
|
|
id="opendoar____::4dcf435435894a4d0972046fc566af76"/>
|
24 |
|
|
<collectedfrom name="Tropmed Central Antwerp"
|
25 |
|
|
id="opendoar____::4dcf435435894a4d0972046fc566af76"/>
|
26 |
|
|
<collectedfrom name="Tropmed Central Antwerp"
|
27 |
|
|
id="opendoar____::4dcf435435894a4d0972046fc566af76"/>
|
28 |
|
|
<collectedfrom name="Wageningen Yield" id="opendoar____::d709f38ef758b5066ef31b18039b8ce5"/>
|
29 |
|
|
<pid classid="" classname="" schemeid="" schemename=""/>
|
30 |
|
|
<datainfo>
|
31 |
|
|
<inferred>true</inferred>
|
32 |
|
|
<deletedbyinference>false</deletedbyinference>
|
33 |
|
|
<trust>0.9</trust>
|
34 |
|
|
<inferenceprovenance>dedup person</inferenceprovenance>
|
35 |
|
|
<provenanceaction classid="sysimport:crosswalk:repository"
|
36 |
|
|
classname="sysimport:crosswalk:repository" schemeid="dnet:provenanceActions"
|
37 |
|
|
schemename="dnet:provenanceActions"/>
|
38 |
|
|
</datainfo>
|
39 |
|
|
<rels>
|
40 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
41 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
42 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
43 |
|
|
>od______1507::fc25fc3c8fd6a69e2e7d9509e965b8c7</to>
|
44 |
|
|
<ranking>2</ranking>
|
45 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
46 |
|
|
schemename="dnet:dataCite_title">Immunoblot characterization of IgG, IgM and IgE
|
47 |
|
|
antibodies elicited during the course of fatal and non-fatal infections of
|
48 |
|
|
Plasmodium berghei in DBA/2 and Balb/c mice</title>
|
49 |
|
|
<dateofacceptance>1997-01-01</dateofacceptance>
|
50 |
|
|
<resulttype classid="publication" classname="publication"
|
51 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
52 |
|
|
</rel>
|
53 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
54 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
55 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
56 |
|
|
>od_______370::8a985e06c6f3eee83f53592bd031e760</to>
|
57 |
|
|
<ranking>6</ranking>
|
58 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
59 |
|
|
schemename="dnet:dataCite_title">Development and evaluation of simplified
|
60 |
|
|
molecular diagnostic devices for malaria</title>
|
61 |
|
|
<dateofacceptance>2011-01-01</dateofacceptance>
|
62 |
|
|
<resulttype classid="publication" classname="publication"
|
63 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
64 |
|
|
</rel>
|
65 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
66 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
67 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
68 |
|
|
>od______1507::ce082daeff49e07c39414a04bb0050e0</to>
|
69 |
|
|
<ranking>7</ranking>
|
70 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
71 |
|
|
schemename="dnet:dataCite_title">Susceptibility of Grammomys surdaster thicket
|
72 |
|
|
rats to Trypanosoma brucei gambiense infection</title>
|
73 |
|
|
<dateofacceptance>2005-01-01</dateofacceptance>
|
74 |
|
|
<publisher>Oxford</publisher>
|
75 |
|
|
<resulttype classid="publication" classname="publication"
|
76 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
77 |
|
|
</rel>
|
78 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
79 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
80 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
81 |
|
|
>od______1507::5cb5ba4983f401222c3763f251aa9c35</to>
|
82 |
|
|
<ranking>4</ranking>
|
83 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
84 |
|
|
schemename="dnet:dataCite_title">Antimalarial efficacy of chloroquine,
|
85 |
|
|
amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine +
|
86 |
|
|
artesunate and sulphadoxine-pyrimethamine + artesunate in Huambo and Bi
|
87 |
|
|
provinces, central Angola</title>
|
88 |
|
|
<dateofacceptance>2005-01-01</dateofacceptance>
|
89 |
|
|
<publisher>Amsterdam</publisher>
|
90 |
|
|
<resulttype classid="publication" classname="publication"
|
91 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
92 |
|
|
</rel>
|
93 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
94 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
95 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
96 |
|
|
>od______1507::5388d288543f0e0ffed7f9b732d48ccd</to>
|
97 |
|
|
<ranking>7</ranking>
|
98 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
99 |
|
|
schemename="dnet:dataCite_title">Efficacy of amodiaquine alone and combined with
|
100 |
|
|
sulfadoxine-pyrimetham ine and of sulfadoxine pyrimethamine combined with
|
101 |
|
|
artesunate</title>
|
102 |
|
|
<dateofacceptance>2003-01-01</dateofacceptance>
|
103 |
|
|
<resulttype classid="publication" classname="publication"
|
104 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
105 |
|
|
</rel>
|
106 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
107 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
108 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
109 |
|
|
>dedup_wf_001::174650fd171be47a3cf4fce4feb5562b</to>
|
110 |
|
|
<ranking>5</ranking>
|
111 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
112 |
|
|
schemename="dnet:dataCite_title">Epidemiology of forest malaria in central
|
113 |
|
|
Vietnam: a large scale cross-sectional survey</title>
|
114 |
|
|
<dateofacceptance>2005-01-01</dateofacceptance>
|
115 |
|
|
<publisher>BioMed Central</publisher>
|
116 |
|
|
<resulttype classid="publication" classname="publication"
|
117 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
118 |
|
|
</rel>
|
119 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
120 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
121 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
122 |
|
|
>od______1507::eb80f69d953e15ec62912a5de3697507</to>
|
123 |
|
|
<ranking>6</ranking>
|
124 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
125 |
|
|
schemename="dnet:dataCite_title">Is amodiaquine failing in Rwanda? Efficacy of
|
126 |
|
|
amodiaquine alone and combined with artesunate in children with uncomplicated
|
127 |
|
|
malaria</title>
|
128 |
|
|
<dateofacceptance>2004-01-01</dateofacceptance>
|
129 |
|
|
<publisher>Oxford</publisher>
|
130 |
|
|
<resulttype classid="publication" classname="publication"
|
131 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
132 |
|
|
</rel>
|
133 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
134 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
135 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
136 |
|
|
>od______1507::c9b955f1fbcd3c73c928b22975f8d5ec</to>
|
137 |
|
|
<ranking>4</ranking>
|
138 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
139 |
|
|
schemename="dnet:dataCite_title">A randomised trial to assess the safety and
|
140 |
|
|
efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated
|
141 |
|
|
Plasmodium falciparum malaria in Rwanda</title>
|
142 |
|
|
<dateofacceptance>2007-01-01</dateofacceptance>
|
143 |
|
|
<publisher>Amsterdam</publisher>
|
144 |
|
|
<resulttype classid="publication" classname="publication"
|
145 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
146 |
|
|
</rel>
|
147 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
148 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
149 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
150 |
|
|
>dedup_wf_001::eba04aa4429c8d04f7eeefd94f21a25a</to>
|
151 |
|
|
<ranking>13</ranking>
|
152 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
153 |
|
|
schemename="dnet:dataCite_title">Glucose-6-phosphate dehydrogenase deficiency,
|
154 |
|
|
chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African
|
155 |
|
|
children treated for uncomplicated malaria</title>
|
156 |
|
|
<dateofacceptance>2012-01-01</dateofacceptance>
|
157 |
|
|
<publisher>BioMed Central</publisher>
|
158 |
|
|
<resulttype classid="publication" classname="publication"
|
159 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
160 |
|
|
</rel>
|
161 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
162 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
163 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
164 |
|
|
>od______1507::c0825861dca8b0a4d5f016867f2a2ebe</to>
|
165 |
|
|
<ranking>8</ranking>
|
166 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
167 |
|
|
schemename="dnet:dataCite_title">HIV-1 immune suppression and antimalarial
|
168 |
|
|
treatment outcome in Zambian adults with uncomplicated malaria</title>
|
169 |
|
|
<dateofacceptance>2006-01-01</dateofacceptance>
|
170 |
|
|
<publisher>Chicago</publisher>
|
171 |
|
|
<resulttype classid="publication" classname="publication"
|
172 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
173 |
|
|
</rel>
|
174 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
175 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
176 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
177 |
|
|
>dedup_wf_001::f2af926fc3f9c357dc617a8cff4b52ea</to>
|
178 |
|
|
<ranking>5</ranking>
|
179 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
180 |
|
|
schemename="dnet:dataCite_title">Varying efficacy of artesunate+amodiaquine and
|
181 |
|
|
artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated
|
182 |
|
|
falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo
|
183 |
|
|
studies</title>
|
184 |
|
|
<dateofacceptance>2009-01-01</dateofacceptance>
|
185 |
|
|
<publisher>BioMed Central</publisher>
|
186 |
|
|
<resulttype classid="publication" classname="publication"
|
187 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
188 |
|
|
</rel>
|
189 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
190 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
191 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
192 |
|
|
>od______1507::d7f29359affdbee832868b0db1635114</to>
|
193 |
|
|
<ranking>6</ranking>
|
194 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
195 |
|
|
schemename="dnet:dataCite_title">A randomised trial to assess the efficacy and
|
196 |
|
|
safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated
|
197 |
|
|
Plasmodium falciparum malaria</title>
|
198 |
|
|
<dateofacceptance>2008-01-01</dateofacceptance>
|
199 |
|
|
<publisher>Amsterdam</publisher>
|
200 |
|
|
<resulttype classid="publication" classname="publication"
|
201 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
202 |
|
|
</rel>
|
203 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
204 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
205 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
206 |
|
|
>dedup_wf_001::fcac7e2f0a339fcfae45a13b14b16115</to>
|
207 |
|
|
<ranking>7</ranking>
|
208 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
209 |
|
|
schemename="dnet:dataCite_title">Development, validation and evaluation of a
|
210 |
|
|
rapid PCR-nucleic acid lateral flow immuno-assay for the detection of Plasmodium
|
211 |
|
|
and the differentiation between Plasmodium falciparum and Plasmodium
|
212 |
|
|
vivax</title>
|
213 |
|
|
<dateofacceptance>2012-01-01</dateofacceptance>
|
214 |
|
|
<publisher>BioMed Central</publisher>
|
215 |
|
|
<resulttype classid="publication" classname="publication"
|
216 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
217 |
|
|
</rel>
|
218 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
219 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
220 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
221 |
|
|
>dedup_wf_001::59dc0a2ca29bb4cd2fa414348f1267d3</to>
|
222 |
|
|
<ranking>5</ranking>
|
223 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
224 |
|
|
schemename="dnet:dataCite_title">Extended high efficacy of the combination
|
225 |
|
|
sulphadoxine-pyrimethamine with artesunate in children with uncomplicated
|
226 |
|
|
falciparum malaria on the Benin coast, West Africa</title>
|
227 |
|
|
<dateofacceptance>2009-01-01</dateofacceptance>
|
228 |
|
|
<publisher>London</publisher>
|
229 |
|
|
<resulttype classid="publication" classname="publication"
|
230 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
231 |
|
|
</rel>
|
232 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
233 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
234 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
235 |
|
|
>od______1507::f0adf1d9388ce41dc705ffe839bfbba1</to>
|
236 |
|
|
<ranking>3</ranking>
|
237 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
238 |
|
|
schemename="dnet:dataCite_title">Safety and efficacy of
|
239 |
|
|
dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated
|
240 |
|
|
Plasmodium falciparum malaria in Rwandan children</title>
|
241 |
|
|
<dateofacceptance>2006-01-01</dateofacceptance>
|
242 |
|
|
<publisher>Amsterdam</publisher>
|
243 |
|
|
<resulttype classid="publication" classname="publication"
|
244 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
245 |
|
|
</rel>
|
246 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
247 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
248 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
249 |
|
|
>od______1507::20455df7e298046ef12d7e93592eef72</to>
|
250 |
|
|
<ranking>4</ranking>
|
251 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
252 |
|
|
schemename="dnet:dataCite_title">Relationship between the Pfcrt T76 and the
|
253 |
|
|
Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine
|
254 |
|
|
resistance in Burkina Faso, West Africa</title>
|
255 |
|
|
<dateofacceptance>2003-01-01</dateofacceptance>
|
256 |
|
|
<resulttype classid="publication" classname="publication"
|
257 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
258 |
|
|
</rel>
|
259 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
260 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
261 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
262 |
|
|
>dedup_wf_001::701723266ea63759fe49e2dca8957750</to>
|
263 |
|
|
<ranking>2</ranking>
|
264 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
265 |
|
|
schemename="dnet:dataCite_title">Real-time PCR/MCA assay using fluorescence
|
266 |
|
|
resonance energy transfer for the genotyping of resistance related DHPS-540
|
267 |
|
|
mutations in Plasmodium falciparum</title>
|
268 |
|
|
<dateofacceptance>2008-01-01</dateofacceptance>
|
269 |
|
|
<publisher>London</publisher>
|
270 |
|
|
<resulttype classid="publication" classname="publication"
|
271 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
272 |
|
|
</rel>
|
273 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
274 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
275 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
276 |
|
|
>od______1507::e54a7313786dd867480c47aa60d50224</to>
|
277 |
|
|
<ranking>3</ranking>
|
278 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
279 |
|
|
schemename="dnet:dataCite_title">Drug resistance genotyping in malaria using
|
280 |
|
|
FRET/melt-curve analysis</title>
|
281 |
|
|
<dateofacceptance>2004-01-01</dateofacceptance>
|
282 |
|
|
<resulttype classid="publication" classname="publication"
|
283 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
284 |
|
|
</rel>
|
285 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
286 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
287 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
288 |
|
|
>od______1507::c3ec38ede6ee98fc5ff862276289a5da</to>
|
289 |
|
|
<ranking>8</ranking>
|
290 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
291 |
|
|
schemename="dnet:dataCite_title">In-vitro susceptibility of Plasmodium
|
292 |
|
|
falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area
|
293 |
|
|
of high chloroquine resistance in Rwanda</title>
|
294 |
|
|
<dateofacceptance>2006-01-01</dateofacceptance>
|
295 |
|
|
<publisher>Amsterdam</publisher>
|
296 |
|
|
<resulttype classid="publication" classname="publication"
|
297 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
298 |
|
|
</rel>
|
299 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
300 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
301 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
302 |
|
|
>od______1507::eed09bee1e74eb52095f6db911df45e9</to>
|
303 |
|
|
<ranking>4</ranking>
|
304 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
305 |
|
|
schemename="dnet:dataCite_title">Molecular markers associated with Plasmodium
|
306 |
|
|
falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of
|
307 |
|
|
Congo</title>
|
308 |
|
|
<dateofacceptance>2006-01-01</dateofacceptance>
|
309 |
|
|
<resulttype classid="publication" classname="publication"
|
310 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
311 |
|
|
</rel>
|
312 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
313 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
314 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
315 |
|
|
>od______1507::d7fa35733d7d2a6b4db0db15aa34d30b</to>
|
316 |
|
|
<ranking>4</ranking>
|
317 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
318 |
|
|
schemename="dnet:dataCite_title">Sulfadoxine-pyrimethamine efficacy and
|
319 |
|
|
selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its
|
320 |
|
|
introduction as intermittent preventive treatment for pregnant women</title>
|
321 |
|
|
<dateofacceptance>2007-01-01</dateofacceptance>
|
322 |
|
|
<resulttype classid="publication" classname="publication"
|
323 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
324 |
|
|
</rel>
|
325 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
326 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
327 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
328 |
|
|
>od______1507::db7267e4a41200817ad02e8558dce102</to>
|
329 |
|
|
<ranking>2</ranking>
|
330 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
331 |
|
|
schemename="dnet:dataCite_title">Plasmodium falciparum genotyping by
|
332 |
|
|
microsatellites as a method to distinguish between recrudescent and new
|
333 |
|
|
infections</title>
|
334 |
|
|
<dateofacceptance>2005-01-01</dateofacceptance>
|
335 |
|
|
<resulttype classid="publication" classname="publication"
|
336 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
337 |
|
|
</rel>
|
338 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
339 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
340 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
341 |
|
|
>od______1507::02465bf7e178a1d43aeba672afcdd523</to>
|
342 |
|
|
<ranking>4</ranking>
|
343 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
344 |
|
|
schemename="dnet:dataCite_title">Malaria transmission intensity and the rate of
|
345 |
|
|
spread of chloroquine resistant Plasmodium falciparum: why have theoretical
|
346 |
|
|
models generated conflicting results?</title>
|
347 |
|
|
<dateofacceptance>2006-01-01</dateofacceptance>
|
348 |
|
|
<resulttype classid="publication" classname="publication"
|
349 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
350 |
|
|
</rel>
|
351 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
352 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
353 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
354 |
|
|
>od______1507::2ed167775d38f12c675686dd06908739</to>
|
355 |
|
|
<ranking>3</ranking>
|
356 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
357 |
|
|
schemename="dnet:dataCite_title">Rodent malaria in the natural host; irradiated
|
358 |
|
|
sporozoites of Plasmodium berghei induce liver-stage specific immune responses
|
359 |
|
|
in the natural host Grammomys surdaster and protect immunized Grammomys against
|
360 |
|
|
P. berghei sporozoite challenge</title>
|
361 |
|
|
<dateofacceptance>2001-01-01</dateofacceptance>
|
362 |
|
|
<resulttype classid="publication" classname="publication"
|
363 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
364 |
|
|
</rel>
|
365 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
366 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
367 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
368 |
|
|
>od______1507::a8f6e31b7123ebc028ff606e71430fdc</to>
|
369 |
|
|
<ranking>3</ranking>
|
370 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
371 |
|
|
schemename="dnet:dataCite_title">Pathogen genotyping in polyclonal infections:
|
372 |
|
|
application of a fluorogenic polymerase-chain-reaction assay in malaria</title>
|
373 |
|
|
<dateofacceptance>2003-01-01</dateofacceptance>
|
374 |
|
|
<publisher>Chicago</publisher>
|
375 |
|
|
<resulttype classid="publication" classname="publication"
|
376 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
377 |
|
|
</rel>
|
378 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:rootToEntity)"
|
379 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
380 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
381 |
|
|
>dedup_wf_001::bcc87af506a8fa1d70c113fc8d7800a0</to>
|
382 |
|
|
<ranking>5</ranking>
|
383 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
384 |
|
|
schemename="dnet:dataCite_title">Adding artesunate to sulphadoxine-pyrimethamine
|
385 |
|
|
greatly improves the treatment efficacy in children with uncomplicated
|
386 |
|
|
falciparum malaria on the coast of Benin, West Africa</title>
|
387 |
|
|
<dateofacceptance>2007-01-01</dateofacceptance>
|
388 |
|
|
<publisher>London</publisher>
|
389 |
|
|
<resulttype classid="publication" classname="publication"
|
390 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
391 |
|
|
</rel>
|
392 |
|
|
<rel inferred="true" trust="0.9" inferenceprovenance="dedup (BuildRoots p:entityToRoot)"
|
393 |
|
|
provenanceaction="sysimport:crosswalk:repository">
|
394 |
|
|
<to class="author" scheme="dnet:personroles" type="result"
|
395 |
|
|
>od______1507::a64458296d0fbf304efa9084f6f571d2</to>
|
396 |
|
|
<ranking>5</ranking>
|
397 |
|
|
<title classid="main title" classname="main title" schemeid="dnet:dataCite_title"
|
398 |
|
|
schemename="dnet:dataCite_title">Usefulness of the Plasmodium falciparum
|
399 |
|
|
chloroquine resistance transporter T76 genotype failure index for the estimation
|
400 |
|
|
of in vivo chloroquine resistance in Burkina Faso</title>
|
401 |
|
|
<dateofacceptance>2005-01-01</dateofacceptance>
|
402 |
|
|
<resulttype classid="publication" classname="publication"
|
403 |
|
|
schemeid="dnet:result_typologies" schemename="dnet:result_typologies"/>
|
404 |
|
|
</rel>
|
405 |
|
|
</rels>
|
406 |
|
|
<children> </children>
|
407 |
|
|
</oaf:person>
|
408 |
|
|
</oaf:entity>
|